American Journal of Psychiatry

Noninvasive brain stimulation technologies such as transcranial electrical and magnetic stimulation (tES and TMS) are emerging neuromodulation therapies that are being used to target the neural substrates of substance use disorders. By the end of 2022, ...

https://doi.org/10.1176/appi.ajp.20221022

pdf

abstract

full text

CME

SAVE ARTICLE

Articles

CME

Effects of Bundling Medication for Opioid Use Disorder With an mHealth Intervention Targeting Addiction: A Randomized Clinical Trial

Publication date: 04 October 2023

Pages115–124

Objective: Medication for opioid use disorder (MOUD) improves treatment retention and reduces illicit opioid use. A-CHESS is an evidence-based smartphone intervention shown to improve addiction-related behaviors. The authors tested the efficacy of MOUD ...

https://doi.org/10.1176/appi.ajp.20230055

CMEVideo

Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial

Publication date: 10 January 2024

Pages125–134

Objective: This randomized clinical trial evaluated the efficacy of Mindfulness-Oriented Recovery Enhancement (MORE) among past and present U.S. military personnel with prescriptions for long-term opioid therapy for chronic pain. Methods: In this clinical ...

https://doi.org/10.1176/appi.ajp.20230272

The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS)

Publication date: 29 November 2023

Pages135–143

Objective: Cannabis use is common among individuals with opioid use disorder, but it remains unclear whether cannabis use is associated with an increase or a reduction in illicit opioid use. To overcome limitations identified in previous longitudinal ...

https://doi.org/10.1176/appi.ajp.20230088

Audio

Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019

Publication date: 29 November 2023

Pages144–152

Objective: Cannabis use disorder diagnoses are increasing among U.S. adults and are more prevalent among people with comorbid psychiatric disorders. Recent changes in cannabis laws, increasing cannabis availability, and higher-potency cannabis may have ...

https://doi.org/10.1176/appi.ajp.20230168

Video

Association of Cortico-Striatal Engagement During Cue Reactivity, Reappraisal, and Savoring of Drug and Non-Drug Stimuli With Craving in Heroin Addiction

Publication date: 12 July 2023

Pages153–165

Objective: The authors investigated cortico-striatal reactivity to drug cues (as compared with neutral and food cues), drug cue reappraisal, food cue savoring, and their correlations with heroin craving in individuals with heroin use disorder compared with ...

https://doi.org/10.1176/appi.ajp.20220759

Letters to the Editor

Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences

Michael S. Scheeringa, M.D.

Publication date: 01 February 2024

Pages166–167https://doi.org/10.1176/appi.ajp.20230223

Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences: Response to Scheeringa

Publication date: 01 February 2024

Pages167–168https://doi.org/10.1176/appi.ajp.20230223r

Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention

Publication date: 01 February 2024

Page168https://doi.org/10.1176/appi.ajp.20230467

Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.

Publication date: 01 February 2024

Pages168–169https://doi.org/10.1176/appi.ajp.20230522

Misrepresentation of Options for Treatment of Opioid Use Disorder in the General Hospital

Publication date: 01 February 2024

Pages169–170https://doi.org/10.1176/appi.ajp.20230656

American Journal of Psychiatry

Editor’s Note

New Developments in Understanding and Treating Opiate and Cannabis Use Disorders

Editorials

Can Smartphone-Based Support Apps Add Value to the Treatment of Opioid Use Disorder?

MORE Is Less Pain and Less Opioid Misuse: A Mindful Remedy

Evaluating Associations Between Cannabis and Heroin Use

Drug Cues Trigger Corticolimbic Hyperreactivity in Heroin Users

Commentary

Toward a Harm Reduction Approach to Cannabis Use Disorder

Review and Overview

Converging Evidence for Frontopolar Cortex as a Target for Neuromodulation in Addiction Treatment

Articles

Effects of Bundling Medication for Opioid Use Disorder With an mHealth Intervention Targeting Addiction: A Randomized Clinical Trial

Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial

The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS)

Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019

Association of Cortico-Striatal Engagement During Cue Reactivity, Reappraisal, and Savoring of Drug and Non-Drug Stimuli With Craving in Heroin Addiction

Letters to the Editor

Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences

Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences: Response to Scheeringa

Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention

Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.

Misrepresentation of Options for Treatment of Opioid Use Disorder in the General Hospital

Past Issues

Vol. 181 | No. 12

Vol. 181 | No. 11

Vol. 181 | No. 10

Vol. 181 | No. 9